SCHEMBL4309282

SCHEMBL4309282

Oc1ccc(-c2cnc3ccc4ccncc4c3c2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 9/20 1.00
ESR2 Q92731 1/20 0.54
PDGFRB P09619 4/20 0.54
PDGFRA P16234 4/20 0.54
DYRK1A Q13627 3/20 0.47
DYRK1B Q9Y463 3/20 0.47
MAP4K4 O95819 1/20 0.47
CDK8 P49336 1/20 0.47
CLK2 P49760 1/20 0.47
CDK7 P50613 1/20 0.47
CDK9 P50750 1/20 0.47
CDK5 Q00535 1/20 0.47
ACVR1 Q04771 1/20 0.47
ROCK1 Q13464 1/20 0.47
LRRK2 Q5S007 1/20 0.47
CLK4 Q9HAZ1 1/20 0.47
EGFR P00533 1/20 0.44
USP7 Q93009 1/20 0.43
MEN1 O00255 1/20 0.42
NPC1 O15118 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30249716 1.00 MAPK10 (1.00) MAPK10ESR2PDGFRBPDGFRADYRK1A
SCHEMBL29041422 0.73 MAPK10 (0.57) MAPK10PDGFRBPDGFRADYRK1ACLK1
SCHEMBL18774836 0.73 MAPK10 (0.60) MAPK10DYRK1AMEN1KMT2AMET
SCHEMBL11411063 0.72 MAPK10 (0.58) MAPK10
SCHEMBL28191731 0.71 PRKCZ (0.68) MAPK10ESR2PDGFRBPDGFRADYRK1A
SCHEMBL7284233 0.71 ESR2 (0.61) MAPK10ESR2PDGFRBPDGFRADYRK1A
SCHEMBL3017525 0.71 ESR2 (1.00) MAPK10ESR2PDGFRBPDGFRADYRK1A
SCHEMBL18774852 0.71 MAPK10 (0.60) MAPK10PDGFRBPDGFRAMEN1KMT2A
SCHEMBL31060586 0.70 PDGFRB (1.00) MAPK10ESR2PDGFRBPDGFRADYRK1A
SCHEMBL23935177 0.69 MAPK10 (0.69) MAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3681504-B1 METHODS OF DETECTION USING X-RAY FLUORESCENCE ICAGEN INC (US) 2023-08-23 EP disclosed
US-11573224-B2 Methods of detection using X-ray fluorescence ICAGEN, LLC (US) 2023-02-07 US disclosed
US-11446398-B2 Regulated biocircuit systems OBSIDIAN THERAPEUTICS, INC. (US) 2022-09-20 US disclosed
US-20210254056-A1 IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS CAMP4 THERAPEUTICS CORPORATION 2021-08-19 US disclosed
US-10877035-B2 Advanced drug development and manufacturing ICAGEN, LLC (US) 2020-12-29 US disclosed
US-20200278346-A1 METHODS OF DETECTION USING X-RAY FLUORESCENCE ADJACENT ACQUISITION CO., LLC 2020-09-03 US disclosed
EP-3681504-A1 METHODS OF DETECTION USING X-RAY FLUORESCENCE Icagen, Inc. (US) 2020-07-22 EP disclosed
US-20190192691-A1 REGULATED BIOCIRCUIT SYSTEMS OBSIDIAN THERAPEUTICS, INC. 2019-06-27 US disclosed
WO-2019055754-A1 METHODS OF DETECTION USING X-RAY FLUORESCENCE ICAGEN, INC. (US) 2019-03-21 WO disclosed
US-20150309021-A1 Advanced Drug Development and Manufacturing LOS ALAMOS NATIONAL SECURITY, LLC 2015-10-29 US disclosed
EP-2511844-B1 X-ray microscope XRPRO SCIENCES INC (US) 2015-08-12 EP disclosed
EP-2511844-A2 Advanced drug development and manufacturing Los Alamos National Security, LLC (US) 2012-10-17 EP disclosed
EP-2084519-B1 X-RAY FLUORESCENCE ANALYSIS METHOD LOS ALAMOS NAT SECURITY LLC (US) 2012-08-01 EP disclosed
EP-2084519-A2 ADVANCED DRUG DEVELOPMENT AND MANUFACTURING Los Alamos National Security, LLC (US) 2009-08-05 EP disclosed
WO-2008127291-A2 ADVANCED DRUG DEVELOPMENT AND MANUFACTURING LOS ALAMOS NATIONAL SECURITY, LLC (US) 2008-10-23 WO disclosed
US-20080220441-A1 Advanced drug development and manufacturing THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2008-09-11 US disclosed